Immunocore Holdings IMCR
NASDAQ IMCR
$32.38 +0.65 (+2.05%)
At close: Nov 10, 2026 · 4:00 PM EST

Immunocore Holdings (IMCR) Short term Debt (2019 - 2024)

Updated

Immunocore Holdings (IMCR) posted Short term Debt of $48.21 million for Q3 2024.

Analysis

Immunocore Holdings (IMCR) Short term Debt (2019 - 2024) Analysis & Trends

At the end of FY2019, Immunocore Holdings' Short term Debt came in at $24.63 million.

  • The Q3 2024 figure stands as the lowest quarterly Short term Debt since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Immunocore Holdings 1.63 Bn -1.86 Bn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 48.21 Mn
Dec 31, 2019 25.12 Mn
API Access

Immunocore Holdings Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IMCR&period=max&api_key=YOUR_API_KEY